MolecularMD's Series B - II Round

MolecularMD raised a round of funding on May 20, 2013. Investors include Ballast Point Ventures.

MolecularMD is a provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in Molecu…

Articles about MolecularMD's Series B - II Round: